by American College of Radiation Oncology
The ACRO Podcast is developed by the nation's leading radiation oncologists and is designed to provide clinicians and program leaders with critically important clinical, business, and advocacy content to advance cancer care and the careers of those professionals we represent. The ACRO Podcast is the latest tool developed by the American College of Radiation Oncology which is the essential professional society for success in the day-to-day practice of radiation oncology.
Language
🇺🇲
Publishing Since
12/31/2022
Email Addresses
1 available
Phone Numbers
0 available
February 21, 2025
<p>In this episode of the ACRO podcast CURiE edition, CURiE Disease Site Lead Dr. Jennifer Lee speaks with author Dr. Christopher Jahraus about his published article, "ACROPath Oligometastases: The American College of Radiation Oncology Clinical Pathway." ACROPath® is a major initiative of ACRO that aims to present aggregated clinical pathway data in a highly usable format that is readily accessible to clinicians at the point of care in real time. The oligometastases pathway is the first published algorithm in this collection, with additional pathways anticipated in future publications.Contemporary Updates: Radiotherapy Innovation & Evidence (CURiE) is the official publication platform of the American College of Radiation Oncology through the Cureus Journal of Medical Science.Read the article here: <a href="https://www.cureus.com/articles/290108-acropath-oligometastases-the-american-college-of-radiation-oncology-clinical-pathway" target="_blank" rel="noopener noreferer">https://www.cureus.com/articles/290108-acropath-oligometastases-the-american-college-of-radiation-oncology-clinical-pathway</a></p>
January 2, 2025
<p>ACRO's SOAP (Spotlight on Advocacy and Policy) Podcast provides public policy awareness to the radiation oncology community. During this episode, our hosts Drs. Tarita Thomas and Anna Brown of the ACRO Government Relations & Economics Committee (GREC) discuss the development of the Medicare Physician Fee Schedule with Dr. Paul Wallner, fellow GREC member, Teri Bedard, Revenue Cycle Coding Strategies, and Jason McKitrick, Liberty Partners Group.</p>
December 5, 2024
ACRO President-elect Brian Lally, MD, and radiation oncology resident Tugce Kutuk, MD, discuss the benefits of GammaTile Brachytherapy for treating brain tumors with targeted radiation therapy.
Laura, Caleb, and Sam
Trudy Wu & Josh No
The Accelerators
Sam and Karine
Katrina Ubell, MD | Master Certified Life and Weight Loss Coach
The New York Times
Bill Maher
Crooked Media
The Uromigos
Dr. Neil Love
American Urological Association
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.